The Role of Mitomycin C in the Treatment of Ocular Surface Squamous Neoplasia
نویسندگان
doi
10.22037/joos.v7i2.45981چکیده
Ocular surface tumors, arising from the squamous epithelium, melanocytes, and lymphocytic resident cells of the conjunctival stroma and cornea, present a challenge in ophthalmic oncology. Ocular surface squamous neoplasia (OSSN) encompasses a spectrum of epithelial squamous malignancies that range from mild to severe dysplasia to invasive squamous cell carcinoma. Traditionally, surgical excision has been the treatment of choice for OSSN, but Mitomycin C (MMC) has emerged as a valuable adjunctive treatment option, decreasing the recurrence rate of these tumors. This review provides an overview of the use of MMC in the management of OSSN, including dosing regimens, complications, and long-term outcomes.